Besides the well-known, frequently mutated, and clinically relevant genes in CRC (e.g., KRAS, BRAF, APC, and PIK3CA), the identification of novel variants by WES offers a possibility to expand our knowledge about CRC formation and assess the region/country-specific variants. Here, BRAF is linked to colorectal carcinoma.